P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ATHX | N/A | N/A | N/A | +7.71% |
ATHX Peer | N/A | N/A | N/A | -81.41% |
Biotechnology Industry | 17.5 | 16.3 | 0.3 | +74.58% |
Health Technology Sector | 32.6 | 21.3 | 0.5 | +30.80% |
S&P 500 Market | 31.1 | 28.1 | 1.1 | +97.11% |
Q2 2022 | Q3 2022 | Q-32768 -32768 | Q-32768 -32768 | |
---|---|---|---|---|
Mean Estimate | -$0.07 | -$0.06 | -$0.05 | -$0.07 |
Previous Mean | -$0.09 | -$0.06 | -$0.05 | N/A |
Standard Deviation | 0.03 | 0.04 | 0.06 | N/A |
Low Estimate | -$0.09 | -$0.09 | -$0.09 | -$0.07 |
High Estimate | -$0.05 | -$0.03 | -$0.01 | -$0.07 |